In vitro diagnostic (IVD) innovation support

IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.

Get to market faster with CPI

From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.

We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.

From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.

Hand with a blue latex glove holding a sealed tube.

In vitro diagnostic (IVD) innovation support

IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.

Get to market faster with CPI

From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.

We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.

From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.

In vitro diagnostic (IVD) innovation support

IVD product development that’s designed for real-world healthcare, including reagents, biosensor technologies, and assay and formulation development.

Get to market faster with CPI

From reagent development and characterisation to assay formulation, product development and scale-up; our expert teams and advanced facilities ensure your devices and reagents are ready to be transferred to a manufacturing environment, getting your product into clinical settings faster.

We also specialise in biosensor innovation, providing novel and robust technologies tailored for real-world healthcare applications. Whether immunoassays or molecular diagnostics, we support the development of reliable, scalable, and impactful solutions to meet urgent diagnostic needs across a wide range of care settings.

From low- and middle-income countries to developed nations, we help ensure access to diagnostics that deliver meaningful outcomes for diverse systems and populations.

Hand with a blue latex glove holding a sealed tube.
  • CLEWS Medical
  • Ventus Medical
  • Touchlight Genetics
  • Stream Bio
  • LiNa Energy
  • JUNE logo with the tagline.
  • CLEWS Medical
  • Ventus Medical
  • Touchlight Genetics
  • Stream Bio
  • LiNa Energy
  • JUNE logo with the tagline.

What we offer

End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.

What we offer

End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.

What we offer

End-to-end support across assay development, reagent scale-up, and biosensor innovation to enable impactful diagnostic solutions.

Reagent development and scale-up

Accelerate the development of your IVD tests with our reagent development, formulation and process optimisation expertise. Our state-of-the-art facilities enable the development of robust engineering biology processes that ensure your regents are ready for seamless transfer to production or manufacturing, delivering cost efficiencies and optimised yields to address critical diagnostic needs.

Reagent development and scale-up

Accelerate the development of your IVD tests with our reagent development, formulation and process optimisation expertise. Our state-of-the-art facilities enable the development of robust engineering biology processes that ensure your regents are ready for seamless transfer to production or manufacturing, delivering cost efficiencies and optimised yields to address critical diagnostic needs.

Assay formulation development

Streamline your assay development journey with our formulation capabilities. We support reagent and assay development, guiding you from proof of concept to scalable processes, enabling the creation of accurate and reliable diagnostic solutions for diverse healthcare settings, including point-of-care applications.

Assay formulation development

Streamline your assay development journey with our formulation capabilities. We support reagent and assay development, guiding you from proof of concept to scalable processes, enabling the creation of accurate and reliable diagnostic solutions for diverse healthcare settings, including point-of-care applications.

Biosensor innovation

Our team works closely with you to design, develop, and optimise biosensor technologies, ensuring they’re specific, sensitive, and tailored to meet the demands of real-world healthcare applications. Whether you’re developing diagnostic tools for point-of-care settings, wearable devices, or laboratory-based systems, we provide the expertise and infrastructure needed to translate your innovative ideas into impactful solutions for global healthcare challenges.

Biosensor innovation

Our team works closely with you to design, develop, and optimise biosensor technologies, ensuring they’re specific, sensitive, and tailored to meet the demands of real-world healthcare applications. Whether you’re developing diagnostic tools for point-of-care settings, wearable devices, or laboratory-based systems, we provide the expertise and infrastructure needed to translate your innovative ideas into impactful solutions for global healthcare challenges.

In vitro diagnostics (IVDs) applications

We support IVD development and the complex path towards user adoption.

Gloved hand holding a small laboratory sample tube with a purple cap.

In vitro diagnostics (IVDs) applications

We support IVD development and the complex path towards user adoption.

Gloved hand holding a small laboratory sample tube with a purple cap.

In vitro diagnostics (IVDs) applications

We support IVD development and the complex path towards user adoption.

Gloved hand holding a small laboratory sample tube with a purple cap.

How we support you

Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.

How we support you

Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.

How we support you

Our end-to-end approach ensures your IVD innovations succeed at every stage of development, from concept to commercialisation.

Demonstrate form and function

Our team of scientists and engineers can accelerate your product’s development with:

  • Design and development of patient-centric diagnostic solutions that are sensitive, selective, specific, reproducible and enhance usability.

  • Fast, cost-effective prototype development to secure early-stage funding.

  • Integration of innovative technologies for a competitive market advantage.

Demonstrate form and function

Our team of scientists and engineers can accelerate your product’s development with:

  • Design and development of patient-centric diagnostic solutions that are sensitive, selective, specific, reproducible and enhance usability.

  • Fast, cost-effective prototype development to secure early-stage funding.

  • Integration of innovative technologies for a competitive market advantage.

Prove manufacturability and scalability

Whatever your innovation, we ensure it’s both manufacturable and scalable.

We provide:

  • Early feasibility studies to assess the manufacturability of IVDs.

  • Scalable production processes to ensure market readiness.

  • Optimisation of manufacturing methods for high-volume, cost-effective production.

Prove manufacturability and scalability

Whatever your innovation, we ensure it’s both manufacturable and scalable.

We provide:

  • Early feasibility studies to assess the manufacturability of IVDs.

  • Scalable production processes to ensure market readiness.

  • Optimisation of manufacturing methods for high-volume, cost-effective production.

Assess and demonstrate commercial viability

We provide the evidence and insights needed to attract investment and partnerships.


Our expertise helps:

  • Discover commercial opportunities and demonstrate scalability to attract investment and licensing opportunities.

  • Conduct user and market research to define commercial opportunities including developing product roadmaps and strategy.

  • Ensure market readiness for expanding diagnostic portfolios.

Assess and demonstrate commercial viability

We provide the evidence and insights needed to attract investment and partnerships.


Our expertise helps:

  • Discover commercial opportunities and demonstrate scalability to attract investment and licensing opportunities.

  • Conduct user and market research to define commercial opportunities including developing product roadmaps and strategy.

  • Ensure market readiness for expanding diagnostic portfolios.

Streamline regulatory compliance

Navigating the complexities of UKCA, CE, or FDA standards is easier with CPI.


Our regulatory experts:

  • Align your IVD innovations with regulatory requirements from the outset giving you confidence for market adoption.

  • Guide you through global regulatory landscapes so you can concentrate on building your business.

  • Ensure compliance, reducing time-to-market and mitigating risks.

Streamline regulatory compliance

Navigating the complexities of UKCA, CE, or FDA standards is easier with CPI.


Our regulatory experts:

  • Align your IVD innovations with regulatory requirements from the outset giving you confidence for market adoption.

  • Guide you through global regulatory landscapes so you can concentrate on building your business.

  • Ensure compliance, reducing time-to-market and mitigating risks.

Secure strategic partnerships

As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare and academia.


We facilitate:

  • Collaboration with trusted partners to share expertise and extend capabilities, enabling you to manage your development through a single point of contact.

  • Discovery and access to leading-edge technologies, supply chains, and industry networks to support your innovation and production scale-up.

  • Strategic partnerships for long-term growth and market adoption in the UK and overseas.

Secure strategic partnerships

As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare and academia.


We facilitate:

  • Collaboration with trusted partners to share expertise and extend capabilities, enabling you to manage your development through a single point of contact.

  • Discovery and access to leading-edge technologies, supply chains, and industry networks to support your innovation and production scale-up.

  • Strategic partnerships for long-term growth and market adoption in the UK and overseas.

  • Scientist in a lab coat and safety glasses operating a 3D printer producing blue printed parts.
    Pipette dispensing a red droplet into rows of small clear laboratory sample tubes.
  • CPI scientist in a lab coat and safety glasses handling sample vials in a laboratory.
    Gloved hand using a multichannel pipette to fill a microplate with pink liquid beside sample bottles.
  • Person performing a self-swab test, holding a swab and sample tube over an instruction sheet.
  • Engineer reviewing a printed circuit board design across two computer monitors at a workstation.
    Two CPI scientists in lab coats and safety glasses reviewing data on a tablet in a laboratory.
  • Close-up of a green printed circuit board being manufactured on automated production equipment.
    Gloved scientist using a pipette to add liquid to a petri dish inside a laboratory fume hood.
  • Close-up of an older person's arm fitted with a wearable monitoring device while two people adjust it.
  • Scientist in a lab coat and safety glasses operating a 3D printer producing blue printed parts.
    Pipette dispensing a red droplet into rows of small clear laboratory sample tubes.
  • CPI scientist in a lab coat and safety glasses handling sample vials in a laboratory.
    Gloved hand using a multichannel pipette to fill a microplate with pink liquid beside sample bottles.
  • Person performing a self-swab test, holding a swab and sample tube over an instruction sheet.
  • Engineer reviewing a printed circuit board design across two computer monitors at a workstation.
    Two CPI scientists in lab coats and safety glasses reviewing data on a tablet in a laboratory.
  • Close-up of a green printed circuit board being manufactured on automated production equipment.
    Gloved scientist using a pipette to add liquid to a petri dish inside a laboratory fume hood.
  • Close-up of an older person's arm fitted with a wearable monitoring device while two people adjust it.
  • Scientist in a lab coat and safety glasses operating a 3D printer producing blue printed parts.
    Pipette dispensing a red droplet into rows of small clear laboratory sample tubes.
  • CPI scientist in a lab coat and safety glasses handling sample vials in a laboratory.
    Gloved hand using a multichannel pipette to fill a microplate with pink liquid beside sample bottles.
  • Person performing a self-swab test, holding a swab and sample tube over an instruction sheet.
  • Engineer reviewing a printed circuit board design across two computer monitors at a workstation.
    Two CPI scientists in lab coats and safety glasses reviewing data on a tablet in a laboratory.
  • Close-up of a green printed circuit board being manufactured on automated production equipment.
    Gloved scientist using a pipette to add liquid to a petri dish inside a laboratory fume hood.
  • Close-up of an older person's arm fitted with a wearable monitoring device while two people adjust it.
£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

£
0
1
2
3
bn

private investment unlocked

0
1
,
0
1
2
3
4
5
6
7
8
0
0
+

R&D projects delivered

0
1
2
0
+

years of experience

0
1
2
,
0
1
2
3
4
5
6
7
8
0
0
+

business collaborations

0
1
2
0
1
2
3
4
5
,
0
0
0

facilities

£
0
1
2
0
1
2
0
m

innovation assets

Trusted by leading organisations

Showing slide 1 of 1
NeoBand

I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

A headshot of Helen McAdam

Helen McAdam

Co-Inventor and Co-Executive

Stream Bio

CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner, CEO Stream Bio

Andy Chaloner

CEO

JUNE logo with the tagline.

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury, CEO KnitRegen

Laura Salisbury

CEO

CLEWS Medical

It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross, Founder CLEWS Medical

Dr Michael Ross

Founder

Ventus Medical

CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

Headshot of David Lawson, Co-Founder

David Lawson

Co-Founder

Trusted by leading organisations

Showing slide 1 of 1
NeoBand

I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

A headshot of Helen McAdam

Helen McAdam

Co-Inventor and Co-Executive

Stream Bio

CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner, CEO Stream Bio

Andy Chaloner

CEO

JUNE logo with the tagline.

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury, CEO KnitRegen

Laura Salisbury

CEO

CLEWS Medical

It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross, Founder CLEWS Medical

Dr Michael Ross

Founder

Ventus Medical

CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

Headshot of David Lawson, Co-Founder

David Lawson

Co-Founder

Trusted by leading organisations

Showing slide 1 of 1
NeoBand

I’ve worked in hospitals for years and believe that clinicians come up with lots of innovative ways to do things better. The stumbling block is getting them to come to fruition. I was looking for people to help me out, struggling, thinking this is never going to happen. CPI listened, they got it, and they’ve made it a reality.

A headshot of Helen McAdam

Helen McAdam

Co-Inventor and Co-Executive

Stream Bio

CPI accelerated our route to commercialisation by a long way, all of the work was done in CPI with access to scientists and equipment. This saved us in the region of £750K — £1m capital investment.

Andy Chaloner, CEO Stream Bio

Andy Chaloner

CEO

JUNE logo with the tagline.

CPI designed the electronics that enabled us to repackage our technology into a wearable and portable form. The collaboration has also enabled us to rigorously test all the components to meet safety standards. We can now bring this technology to more people to help with their stroke rehabilitation.

Laura Salisbury, CEO KnitRegen

Laura Salisbury

CEO

CLEWS Medical

It has been a fantastic experience working alongside CPI. For every obstacle that we’ve come across, the CPI team have been prepared to investigate and find ways around them. Although we've only made early progress along a much longer road to commercialisation, I feel confident that this road has been roughly mapped out by the knowledge and contacts provided by CPI.

Dr Michael Ross, Founder CLEWS Medical

Dr Michael Ross

Founder

Ventus Medical

CPI has played a pivotal role in the development of ENHALE, allowing us to identify the optimum materials and processes for the scalable & sustainable manufacturer of a safe and efficacious medicine.

Headshot of David Lawson, Co-Founder

David Lawson

Co-Founder

Get in touch

Get in touch

Get in touch